CAS 132682-98-5
:Glufosfamida
- (2S,3R,4S,5S,6R)-2-Bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 1-O-{bis[(2-chloroethyl)amino]phosphoryl}-beta-D-glucopyranose
- D 19575
- Glucosylifosfamide mustard
- Glufosfamide,B-D-Glucopyranose, 1-(N,N'-Bis(2-Chloroethyl)Phosphorodiamidate)-
- β-<span class="text-smallcaps">D</span>-Glucopyranose, 1-[N,N′-bis(2-chloroethyl)phosphorodiamidate]
- Glufosfamide
- β-D-Glucopyranose, 1-[N,N′-bis(2-chloroethyl)phosphorodiamidate]
β-D-Glucopyranose, 1-[N,N'-bis(2-chloroethyl)phosphorodiamidate]
CAS:Fórmula:C10H21Cl2N2O7PPureza:96%Peso molecular:383.1627Glufosfamide
CAS:Produto ControladoApplications Glufosfamide is an alkylating cytotoxic agent with increased antitumor selectivity and active transmembrane transport mechanism, that belongs to the oxazaphosphorine class. It is an attractive new agent for cancer therapy in humans.
References Pohl, J., et al.: Cancer Chemother. Pharmacol., 35, 364 (1995); Mazur, L., et al.: Anticancer Drugs, 22, 488 (2011);Fórmula:C10H21Cl2N2O7PCor e Forma:NeatPeso molecular:383.163Glufosfamide
CAS:Glufosfamide is a novel oxazolophosphamide compound with anticancer activity for the study of advanced non-small cell lung cancer.
Fórmula:C10H21Cl2N2O7PPureza:99.72%Cor e Forma:SolidPeso molecular:383.16Glufosfamide
CAS:Glufosfamide is a cytotoxic drug that is used in the treatment of some types of cancer. It is a prodrug that requires conversion to its active form, glufosfamid, by esterase enzymes before it can exert its genotoxic effects. Glufosfamide has shown to be active against platinum-resistant ovarian cancer and solid tumours. This drug also has been shown to inhibit the growth of prostate cancer cells and miapaca-2 cells, which are derived from pancreatic cancer. Glufosfamide has been found to have low toxicity in mice, but there may be adverse reactions when combined with other drugs such as erythromycin or ketoconazole.
Fórmula:C10H21Cl2N2O7PPureza:Min. 95%Peso molecular:383.16 g/mol




